The Deal magazine looks at the biotech sector and how new, creative funding deals are promising to rejuvenate the search for new drugs. Plus, this issue looks at LIBOR's new landscape. Meanwhile, we have an indepth conversation with CD&R's Joseph Rice.

What goes up must come down, and so it would appear as The Deal magazine examines big-league bankruptcy. The theory holds for Tribune as it's new owners weigh its assets. But what about W.R. Grace, as it emerges from bankruptcy having made 22 acquisitions under protection? Plus, the corporate dealmaker 100.

The Deal magazine takes an indepth look at the strategic dealmaking of the packaging industry in the middle market. We also hit the road looking at the startup landscape in the drug development and medical devices sectors in Kalamazoo, Michigan as well as the burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries in Bend, Oregon.

Wanna do M&A? Careful, because here comes the shareholder litigation. When it comes to tech acquisitions, they're getting done -- just too bad companies aren't very good at it. And sovereign wealth funds are back, growing fast.

No one said private equity would be easy, and our annual Private Equity Deals of the Year proves it again with a roundup of 2011's big winners and losers. Also, The Deal magazine takes a look at cowboy capitalism with a trip to Dallas-Fort Worth. Finally, take a look at our sampling of middle-market companies on the auction block.

The Deal magazine travels to Japan to witness the island nation rise again amidst an active streak of dealmaking. Plus, a duet of music-related articles look at the antitrust snares of Universal Music's purchase of EMI assets and the effect that the emergence of digital music is having on copyright laws.

In this issue, The Deal magazine hits the bankruptcy trifecta: the take-no-prisoners battle for Alter Communications; the rise and fall of real estate moguls, the Meruelo brothers; and the bankruptcy league tables. Also, take a look at how Humana has set a new course along the acquisition trail.

The Deal magazine focuses on the middle market by looking at some of its top dealmakers and then gives an overview of what's out there on the auction block. The issue also features an in-depth look at private equity in France and in emerging markets around the world.

The Deal magazine gets in the pilot seat to take a look at American Airlines' bankruptcy, then wonders what will now happen to a beleaguered Reader's Digest. Also, Herb Fritch of HealthSpring may have an answer to the sky-high inflation of the healthcare industry.

What a topsy-turvy, rumbly-tumbly year 2011 turned out to be -- and The Deal magazine takes a look at the M&A Deals of the Year in uncertain times. Also, Edgar Bronfman Jr. sits down for his first interview since selling Warner Music.

Just when you thought it was safe to go back in the water, suddenly it was 2011 -- and The Deal magazine looks back at all the twists and turns of dealmaking. Also in this issue, dealmakers pay back as social entrepreneurs.

'What worrying wall of debt?' The Deal magazine asks. Oh, right, there it is. Plus, the Windy City offers up its own particular brand of private equity, while, farther afield, Big Oil makes a play in Kurdistan.

The Deal magazine tracks down the in-house corporate dealmakers from the top American companies and takes a voyage around the world to explore the valleys and peaks of the travel industry.

The Deal magazine goes back to school and offers a full report on the business of education.

The Deal magazine goes looking for trolls and geeks, and the middle market shows its ups and downs in a trying economy.

Who are the private equity movers and shakers to keep an eye on, and how does Ralph de la Torre look to transform managed care?

The Deal magazine honors this year's Most Admired Corporate Dealmakers and takes a close look at the ups and downs of Wall Street compensation.

The interview issue asks all the pertinent questions to six experts in their respective fields, while the market for multiple sclerosis therapies provides an evocative case study on dealmaking.

The Deal magazine gets up close and personal with faces of the middle market and charts the new hits of the music business as it shifts away from label dominance.

Despite trying financial times, the spotlight shines on the private equity deals of the year that were deftly executed and held to the principle of creating value.